Cyclosporin Metabolism in Human Liver Microsomes and Its Inhibition by Other Drugs
- 1 January 1990
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 66 (1) , 49-52
- https://doi.org/10.1111/j.1600-0773.1990.tb00701.x
Abstract
The metabolism of cyclosporin was studied in human liver microsomes. There was no metabolism in the presence of cytochrome C or carbon monoxide or in the absence of cofactors, suggesting metabolism by cytochrome P‐450 enzymes. The metabolism was inhibited by ketoconazole and erythromycin, by the steroids methylprednisolone and oestradiol, and by the calcium antagonists diltiazem, nifedipine, prenylamine and verapamil. Thesein vitrofindings correlate well with previously published clinical reports suggesting that these drugs may inhibit the metabolism of cyclosporinin vivo.Our observations suggest that metabolic interactions between cyclosporin and other drugsin vivomay be predictedin vitrounder proper experimental conditions.This publication has 28 references indexed in Scilit:
- VERAPAMIL INHIBITS CYCLOSPORIN METABOLISMThe Lancet, 1987
- INFLUENCE OF DILTIAZEM ON CYCLOSPORIN CLEARANCEThe Lancet, 1986
- Possible Interaction between Cyclosporine and ErythromycinNew England Journal of Medicine, 1986
- CYCLOSPORIN INTERACTION WITH DANAZOL AND NORETHISTERONEThe Lancet, 1986
- An acid metabolite of cyclosporineBiochemical and Biophysical Research Communications, 1985
- Effect of Erythromycin on Cyclosporine LevelsNew England Journal of Medicine, 1985
- Toxicity of Cyclosporine during Treatment with AndrogensNew England Journal of Medicine, 1985
- PHARMACOKINETICS OF INTRAVENOUS CYCLOSPORINE IN BONE MARROW TRANSPLANT PATIENTSTransplantation, 1984
- EFFECTS OF CYCLOSPORIN ON PREDNISOLONE METABOLISMThe Lancet, 1984
- RAPID METABOLISM OF CYCLOSPORIN AND PREDNISONE IN KIDNEY TRANSPLANT PATIENT RECEIVING TUBERCULOSTATIC TREATMENTThe Lancet, 1983